Mechanism of action:
- Inhibits the breakdown of GLP-1 by DPP-4 therefore increasing GLP-1 levels resulting in increased glucose-dependent insulin release and decreased
Therapeutic uses:
- Type 2 DM either alone or in combination with metformin.
- They are given orally; most common side effects are headache and nausea.